Compare BioNTech SE - ADR (BNTX) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Ginkgo Bioworks Holdings Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Ginkgo Bioworks Holdings Inc trades at $7.58 (market cap $505.73M). The key difference: BioNTech SE - ADR is far larger — about 46.1× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.
| BNTX | DNA | |
|---|---|---|
Market Cap | $23.31B | $505.73M |
Sector | Health | Health |
52-Week High | $119.34 | $16.14 |
52-Week Low | $83.89 | $5.48 |
Enterprise Value | $6.60B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
